AGILENT TECHNOLOGIES, INC.

(A)
  Report
Delayed Nyse  -  04:03 2022-07-01 pm EDT
119.21 USD   +0.37%
07/01INSIDER SELL : Agilent Technologies
MT
07/01AGILENT TECHNOLOGIES, INC. : Ex-dividend day for
FA
06/21Agilent Laboratory Achieves Green Lab Certification
BU
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
06/27/2022 06/28/2022 06/29/2022 06/30/2022 07/01/2022 Date
120.57(c) 117.06(c) 117.9(c) 118.77(c) 119.21(c) Last
1 805 698 1 426 079 906 648 1 611 981 1 119 770 Volume
-0.59% -2.91% +0.72% +0.74% +0.37% Change
More quotes
Estimated financial data (e) (USD)
Sales 2022 6 707 M - -
Net income 2022 1 236 M - -
Net Debt 2022 1 269 M - -
P/E ratio 2022 28,9x
Yield 2022 0,71%
Sales 2023 7 187 M - -
Net income 2023 1 422 M - -
Net Debt 2023 1 759 M - -
P/E ratio 2023 24,7x
Yield 2023 0,77%
Capitalization 35 609 M 35 609 M -
EV / Sales 2022 5,50x
EV / Sales 2023 5,20x
Nbr of Employees 17 400
Free-Float 99,7%
More Financials
Company
Agilent Technologies, Inc. specializes in the design, manufacturing and marketing of measurement instruments intended primarily for the communications, electronics, life sciences, and chemistry sectors. The activity is organized mainly around three families of products: - electronic measurement instruments; - bio-analytical measurement instruments: used to identify, quantify, and analyze the physical and... 
More about the company
Ratings of Agilent Technologies, Inc.
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
A
More Ratings
All news about AGILENT TECHNOLOGIES, INC.
07/01INSIDER SELL : Agilent Technologies
MT
07/01AGILENT TECHNOLOGIES, INC. : Ex-dividend day for
FA
06/21Agilent Laboratory Achieves Green Lab Certification
BU
06/16Agilent Wins Multiple 2022 Scientists Choice Awards at ASMS
AQ
06/16Agilent Receives MFDS Approval in South Korea for Companion Diagnostic PD-L1 IHC 22C3 p..
AQ
06/16Agilent Showcases ‘Consistent, Greener, Smarter' Approach at Analytica 2022
BU
06/15TRANSCRIPT : Agilent Technologies, Inc. Presents at Goldman Sachs 43rd Annual Global Healt..
CI
06/15Agilent Wins Multiple 2022 Scientists' Choice Awards at ASMS
BU
06/14Merck KGaA Partners With Agilent Technologies For Downstream Process Monitoring
MT
06/14Agilent and Mahidol University Sign MOU for Science Industry Research and Development i..
AQ
06/07Agilent Leverages NVIDIA and AWS Technology to Improve Analysis Speeds of Genomics Bioi..
BU
06/06INSIDER SELL : Agilent Technologies
MT
06/06Agilent Technologies, Inc. Announces New Revolutionary Quadrupole Mass Spectrometers At..
CI
06/06Agilent Announces New Revolutionary Quadrupole Mass Spectrometers at ASMS 2022
BU
06/06Agilent Announces New Oligonucleotide Analysis Software for Biopharma Research
BU
More news
News in other languages on AGILENT TECHNOLOGIES, INC.
07/01VENTE D'INITIÉS : Agilent Technologies
06/14Merck KGaA s'associe à Agilent Technologies pour la surveillance des processus en aval.
06/14Merck KGaA kooperiert mit Agilent bei Prozessanalysetechnologien
06/08Vous reprendrez bien un peu de pétrole ?
06/08EN DIRECT DES MARCHES : Pernod-Ricard, Schneider, Sanofi, Quadient, EDF, Crédit Suisse, In..
More news
Analyst Recommendations on AGILENT TECHNOLOGIES, INC.
More recommendations
Stock Trading Strategies
AGILENT TECHNOLOGIES, INC. - 2021
The stock forcefully approaches new pivot levels
BUY
More Stock Trading Analysis
Chart AGILENT TECHNOLOGIES, INC.
Duration : Period :
Agilent Technologies, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends AGILENT TECHNOLOGIES, INC.
Short TermMid-TermLong Term
TrendsNeutralBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 16
Last Close Price 119,21 $
Average target price 149,13 $
Spread / Average Target 25,1%
EPS Revisions
Managers and Directors
Michael R. McMullen VP & GM-Chemical Analysis Solutions Unit
Robert W. McMahon Chief Financial Officer & Senior Vice President
Boon Hwee Koh Non-Executive Chairman
Darlene J. S. Solomon Chief Technology Officer & Senior Vice President
Katharine Knobil Chief Medical Officer
Sector and Competitors